TAG:
the clinical laboratory
Investors Returning To Lab Industry
By R. Lewis Dark | From the Volume VII No. 9 – June 19, 2000 Issue
SOMETHING BIG IS HAPPENING to the clinical laboratory industry and the anatomic pathology profession. For the first time in six or seven years, the investment community is paying close attention to the laboratory industry. This should be a welcome development for commercial lab owners and anatomic …
Questions Remain About Performance Of Liquid-Prep Paps
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
CEO SUMMARY: During the past five years, several companies entered the lab marketplace with claims that their new Pap test technologies are improvements over conventional Pap smear methods. Armed with investment capital from Wall Street, these companies launched aggressive sales and marke…
BRLI Ready To Leverage Physician Relationship
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: As healthcare E-commerce rapidly approaches, clinical laboratories will find they have a built-in competitive advantage—their existing business relationship and communication links to physician offices. Bio-Reference Laboratories, Inc. is moving rapidly to capitalize on thi…
Columbia/HCA’s $745 Mil Settlement Announced
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: Although Columbia/HCA will pay the feds $745 million as part of its recent settlement, the facts of “Medicare fraud” are far from convincing. Wall Street Journal analyst Holman W. Jenkins, Jr. makes a strong argument that the government was able to pick on Columb…
Columbia/HCA, AmeriPath, Epitope, STC Technologies, Quest Diagnostics
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
COLUMBIA/HCA GETS NEW NAME; ACQUIRES FOUR LONDON HOSPITALS NOW THAT IT HAS A SETTLEMENT with the federal government on civil claims of Medicare fraud, expect a rapid cascade of changes at Columbia/HCA Healthcare Corporation, the nation’s largest for-profit hospital company…
New Automation Tools Ready for Clinical Labs
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
CEO SUMMARY: Evidence grows that workstation automation and modular automation can be cost-effective solutions in the clinical laboratory. But the newest generation of automation technology presents lab administrators with a new challenge. Financial analysis and workplace reengineering ar…
Luminex Raises $83 Mil In Public Stock Offering
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
CEO SUMMARY: During the past year, Luminex Corporation moved swiftly to push its LabMAP™ multiplex testing technology into the bioassay marketplace. It found high interest among companies in the pharmaceutical, diagnostics, and bioresearch industries. Luminex executives say that a numbe…
“May 8, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
There’s another healthcare Ecommerce company starting up. This one’s directed at the clinical laboratory industry. To be called “LabPortal.com,” it’s connected to Golder, Thoma, Cressey, Rauner Inc., Park City Solutions, and American Medical Laboratories. L…
Hospital Labs To Regain Pre-Eminence in Coming Years
By Robert Michel | From the Volume VII No. 6 – April 17, 2000 Issue
CEO SUMMARY: During the past five years, powerful forces in the healthcare marketplace positioned hospital-based laboratories to once again become the dominant force in laboratory testing. But this can only occur if today’s generation of hospital laboratory directors and clinical pathol…
2000’s Movers & Shakers Represent Strong Leaders
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: Its time again for THE DARK REPORT to make its yearly selection of the lab industry’s Movers & Shakers. Individuals chosen for 2000 represent a cross section of laboratory companies. Their successes demonstrate that leadership and vision continue to make a difference, d…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized